Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Axplora Welcomes Martin Meeson as CEO | Contract Pharma
Breaking News, Promotions & Moves

Axplora Welcomes Martin Meeson as CEO

Meeson will bring his expertise to Axplora’s global footprint of 10 sites on 3 continents while continuing to amplify the group’s capabilities and strengths.

Axplora, a partner to Pharma companies and Biotechs for complex APIs, has appointed Martin Meeson as its new Chief Executive Officer (CEO).
 
Meeson succeeds Sylke Hassel. With over two decades of experience in managing and growing businesses globally, he brings a passion for this sector, the customers Axplora supplies and the partnerships it creates. Meeson will bring his expertise to Axplora’s global footprint of 10 sites on 3 continents while continuing to amplify the group’s capabilities and strengths in over 15 technologies including ADCs, Steroids & Industrial Chromatography. He is also committed to fostering growth and efficiency while building enduring partnerships with customers and other stakeholders.
 
Meeson, who took over as CEO of Fujifilm Diosynth Biotechnologies at the start of the pandemic, successfully steered the business through this turbulent period, supporting the development of numerous treatments and vaccines.
 
“What we do is not easy, but it is worthwhile.  In the pursuit of excellence, we must continue to build on our strengths and challenge ourselves to continuously improve for the partners and patients we serve,” Meeson remarked. “When deep technical expertise across the Axplora Group is positively matched with the needs of our over 900 customers, enduring success is realized for all players in the ecosystem.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters